NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / *W EXP 02/10/202
Number of holders
19
Total 13F shares, excl. options
3,430,939
Shares change
-138,126
Total reported value, excl. options
$6,486,000
Value change
-$371,128
Number of buys
1
Number of sells
-7
Price
$1.89

Significant Holders of NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) as of Q4 2021

23 filings reported holding NUVBWS - NUVATION BIO INC - *W EXP 02/10/202 as of Q4 2021.
NUVATION BIO INC - *W EXP 02/10/202 (NUVBWS) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,430,939 shares .
Largest 10 shareholders include 683 Capital Management, LLC (825,323 shares), HIGHBRIDGE CAPITAL MANAGEMENT LLC (387,893 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (266,666 shares), BOXER CAPITAL, LLC (266,666 shares), FRANKLIN RESOURCES INC (266,666 shares), BlackRock Inc. (231,166 shares), Castle Creek Arbitrage, LLC (215,426 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (166,666 shares), Walleye Capital LLC (163,105 shares), and Rock Springs Capital Management LP (134,028 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.